Consulting Case Interview by Bain Associate Consultant
Вставка
- Опубліковано 6 лис 2022
- For more Career and MBA related content, follow: @ZiadShares
In this video, Rhea (a current Bain Associate Consultant) goes through a full Case interview. The question involves both a market entry and market sizing situation. We go through all parts of the case here from:
1) Introduction and Prompt
2) Framework
3) Analysis (Sizing + Brainstorming)
4) Conclusion
Great content! Would be better without the background music imo
she's so eloquent!
she did amazing job! well structured and clear thoughts.
She did a great job 😊
Why this guy a lil too serious tho
I think a company that's expecting an FDA approval (and has gone through all the troubles associated with that) has already made up their mind about getting into the said market 🤷♂
Correct me if I'm wrong
Same thought here!
Trouble + huge investment of time , $$, and resources.
Good but the figures are so off 😅
Her approach is awesome, but she uses ‘awesome’ too often
The number of times she says awesome, it’s very hard to focus on anything else in the beginning.
How much time are you actually entitled to get when thinking of a solution to a case?
You should count no more than 60-90 seconds to lay down your structure, you can gain 60 more seconds if you’re completely able to discuss with your interviewer while you’re writing it down
you get 120 secs if you are lookin hot
Awesome😂, awesome😂, migraine market, awesome😂. Instant pass on hiring.
It was so annoying
❤cool
This is way harder than IB 💀
5:01
She says she's going to estimate the Botox injections market.. I thought we are studying the migraine market
I know what you are saying. Unlike her, you, who are not familiar with the medical lexicon, should ask additional clarifying questions upfront.
Migraine is essentially a severe headache. Botulinum Toxin (BoTox) is both the name of the wrinkle-removing toxin and the name of the company. So she is right that the objective of this case is to estimate the BoTox injections market geared toward resolving migraine. It may be a surprise that this toxin is indeed used to treat some severe headaches.
Did not get why she analysed the Botox market if the question was entering a new market..@@1Piece_Luffy
8:23
how come she assumes the company owns 30% of the market share if they have not joined the market yet?
Like my comment below, you should consider asking more clarifying questions upfront (Ex. "How are other firms treating migraine now? With other substances?").
Since Migraine is merely a disease (extreme headache), you can actually treat it with existing medicine you can find in CVS or Walgreens. Therefore, you should not assume that your client can enjoy 100% market share. She is saying that a 30% share is not too excessive because BoTox is a product line registered with a trademark by AbbVie, the 6th largest medical company in North America.
Nevertheless, I think she went a tad aggressive. I would've picked 10% or 15% (at that moment, since I would've asked competitive landscape in the later bucket) since there are quite a number of giant medicine groups. But whenever the interviewer says OK, you are fine with whatever number you choose.
I think many of her assumptions are not that reasonable, sometimes maybe the interviewer only cares about the analyzing process but not the figures.
I think she assumes that the company could potentially get upto a 30% market share which is much on the higher side as the market is not growing and there are existing established competitors
Where is the Top Down Approach?
She does talks about market size, competition, price elasticity, us population, people suffering from headaches, total no of patients, injections per patient. So isn’t that top down approach?
The music is so unnecessary… great otherwise :)
oh my god the interviewer is so mean
Total crap…
She forget a lot and made it school kid easy..
1) Governance
2) Insurance
3) Age Groups
4) Patent on and old product, Patient renewal
5) Practice
6) Cheaper competitors
7) Phase 2 Testing
All the things that matter and maybe more I forgot…
I feel insurance companies should not have been overlooked